Edgewise Therapeutics (EWTX) News Today $15.35 -0.30 (-1.92%) Closing price 04:00 PM EasternExtended Trading$15.65 +0.30 (+1.96%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EWTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Edgewise Therapeutics, Inc. $EWTX Shares Acquired by HighMark Wealth Management LLCOctober 3 at 6:58 AM | marketbeat.comEdgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing RulesOctober 2, 2025 | prnewswire.comEdgewise Therapeutics to Present on Sevasemten for Becker and Duchenne Muscular Dystrophies at the 30th International Annual Congress of the World Muscle SocietyOctober 2, 2025 | prnewswire.comThe Goldman Sachs Group Initiates Coverage on Edgewise Therapeutics (NASDAQ:EWTX)September 27, 2025 | americanbankingnews.comEdgewise Therapeutics (NASDAQ:EWTX) Raised to "Hold" at The Goldman Sachs GroupSeptember 26, 2025 | marketbeat.comGoldman Sachs assigns Neutral rating to Edgewise TherapeuticsSeptember 25, 2025 | msn.comGoldman Sachs Initiates Coverage of Edgewise Therapeutics (EWTX) with Neutral RecommendationSeptember 25, 2025 | msn.comEdgewise Therapeutics (NASDAQ:EWTX) Trading Down 8.5% - Here's WhySeptember 25, 2025 | marketbeat.comThe Goldman Sachs Group Begins Coverage on Edgewise Therapeutics (NASDAQ:EWTX)September 25, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Trading 8.5% Higher - Should You Buy?September 24, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 4.8% - Here's What HappenedSeptember 20, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Trading 11.3% Higher - Time to Buy?September 19, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Average Recommendation of "Moderate Buy" by AnalystsSeptember 18, 2025 | marketbeat.comEdgewise Therapeutics, Inc. $EWTX Shares Purchased by Goldman Sachs Group Inc.September 16, 2025 | marketbeat.comFred Alger Management LLC Takes Position in Edgewise Therapeutics, Inc. $EWTXSeptember 13, 2025 | marketbeat.comAmundi Cuts Stock Position in Edgewise Therapeutics, Inc. $EWTXSeptember 13, 2025 | marketbeat.comWoodline Partners LP Raises Stake in Edgewise Therapeutics, Inc. $EWTXSeptember 12, 2025 | marketbeat.comEdgewise Therapeutics, Inc. $EWTX Position Increased by Adage Capital Partners GP L.L.C.September 9, 2025 | marketbeat.comParkman Healthcare Partners LLC Acquires 44,234 Shares of Edgewise Therapeutics, Inc. $EWTXSeptember 8, 2025 | marketbeat.comEdgewise Therapeutics, Inc. $EWTX Shares Sold by Granahan Investment Management LLCSeptember 7, 2025 | marketbeat.comEFG Asset Management North America Corp. Increases Holdings in Edgewise Therapeutics, Inc. $EWTXSeptember 7, 2025 | marketbeat.comEventide Asset Management LLC Purchases Shares of 568,310 Edgewise Therapeutics, Inc. $EWTXSeptember 7, 2025 | marketbeat.comCormorant Asset Management LP Has $90.24 Million Stock Position in Edgewise Therapeutics, Inc. $EWTXSeptember 6, 2025 | marketbeat.com20,000 Shares in Edgewise Therapeutics, Inc. $EWTX Acquired by ADAR1 Capital Management LLCSeptember 4, 2025 | marketbeat.comFirst Light Asset Management LLC Buys 1,071,651 Shares of Edgewise Therapeutics, Inc. $EWTXSeptember 4, 2025 | marketbeat.comEdgewise Therapeutics, Inc. $EWTX Shares Acquired by MPM Bioimpact LLCSeptember 4, 2025 | marketbeat.comEdgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing RulesSeptember 3, 2025 | prnewswire.comBraidwell LP Has $54.09 Million Position in Edgewise Therapeutics, Inc. $EWTXSeptember 3, 2025 | marketbeat.comWellington Management Group LLP Sells 89,590 Shares of Edgewise Therapeutics, Inc. $EWTXSeptember 2, 2025 | marketbeat.comDriehaus Capital Management LLC Trims Stock Holdings in Edgewise Therapeutics, Inc. $EWTXSeptember 1, 2025 | marketbeat.comEdgewise Therapeutics, Inc. $EWTX Shares Acquired by Siren L.L.C.August 31, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Insider Sells $1,460,000.00 in StockAugust 29, 2025 | insidertrades.comNuveen LLC Buys New Position in Edgewise Therapeutics, Inc. $EWTXAugust 29, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Average Rating of "Moderate Buy" by AnalystsAugust 26, 2025 | marketbeat.comCandriam S.C.A. Decreases Position in Edgewise Therapeutics, Inc. $EWTXAugust 25, 2025 | marketbeat.comVanguard Group Inc. Has $94.48 Million Holdings in Edgewise Therapeutics, Inc. $EWTXAugust 25, 2025 | marketbeat.comAberdeen Group plc Buys 134,982 Shares of Edgewise Therapeutics, Inc. $EWTXAugust 23, 2025 | marketbeat.comJPMorgan Chase & Co. Issues Pessimistic Forecast for Edgewise Therapeutics (NASDAQ:EWTX) Stock PriceAugust 21, 2025 | marketbeat.comJPMorgan cuts Edgewise target, remains from Analyst Focus ListAugust 20, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXAugust 17, 2025 | globenewswire.comDeutsche Bank AG Has $8.27 Million Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)August 17, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) CFO R Michael Carruthers Sells 1,428 SharesAugust 16, 2025 | marketbeat.comInsider Selling: Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Insider Sells 1,907 Shares of StockAugust 16, 2025 | marketbeat.comInsider Selling: Edgewise Therapeutics, Inc. (NASDAQ:EWTX) General Counsel Sells 2,098 Shares of StockAugust 16, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) CMO Sells $38,322.18 in StockAugust 16, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) CEO Kevin Koch Sells 7,972 SharesAugust 16, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXAugust 16, 2025 | prnewswire.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) CFO Sells $19,120.92 in StockAugust 15, 2025 | insidertrades.comEdgewise Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law FirmAugust 14, 2025 | gurufocus.comEdgewise Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law FirmAugust 14, 2025 | globenewswire.com Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EWTX Media Mentions By Week EWTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EWTX News Sentiment▼0.630.54▲Average Medical News Sentiment EWTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EWTX Articles This Week▼37▲EWTX Articles Average Week Get the Latest News and Ratings for EWTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Edgewise Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Grifols News Today Rhythm Pharmaceuticals News Today Avidity Biosciences News Today Abivax News Today Legend Biotech News Today Cytokinetics News Today Nuvalent News Today Axsome Therapeutics News Today TG Therapeutics News Today CRISPR Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EWTX) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredIs This Warren’s Buffett’s #1 AI Investment?Did you know that Warren Buffett is investing in what Jeff Brown believes will be the next generation of artif...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
